Hyperfine HYPR
NASDAQ HYPR
$0.79 -0.03 (-4.08%)
As of: Sep 9, 2026 · 2:29 PM EDT

Hyperfine (HYPR) EBITDA Margin Growth (3y) (2024 - 2026)

Analysis

Hyperfine (HYPR) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 GE HealthCare Technologies 29.58 Bn 27.48 Bn 2.18 Bn 212.00
2 Lantheus Holdings 6.58 Bn 5.98 Bn 241.86 Mn -1,277.00
3 Heartflow 4.09 Bn 3.71 Bn 53.19 Mn -
4 Neogen 2.58 Bn 2.40 Bn 107.80 Mn -831.00
5 Butterfly Network 1.98 Bn 1.86 Bn 23.29 Mn 12,721.00
6 Ceribell 924.18 Mn 794.92 Mn 25.94 Mn -
7 QuidelOrtho 876.63 Mn 753.23 Mn - -
8 Varex Imaging 778.85 Mn 679.65 Mn 76.70 Mn 41.00
9 Prenetics Global 342.58 Mn 283.53 Mn 30.20 Mn 18,294.00
10 Hyperfine 78.67 Mn 33.91 Mn 1.98 Mn 12,888.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12,888.00
Mar 31, 2026 27,542.00
Dec 31, 2025 81,222.00
Sep 30, 2025 30,614.00
Jun 30, 2025 115,695.00
Mar 31, 2025 106,513.00
Dec 31, 2024 551,945.00
Sep 30, 2024 411,686.00
Jun 30, 2024 377,560.00
Mar 31, 2024 203,479.00